4Lindstrom E,Bingefors K. Patient compliance with drug therapy in schizophrenia. Pharmacoeconomics,2000,18(2):106-124.
5Murawiec S. Subjective aspects of psychopharmacology in schizophrenia. Psychiatr Pol,1999,33(1):25-35.
6Herz MI,Lamberti JS,Mintz J,et al. A program for relapse prevention in schizophrenia:a controlled study. Arch Gen Psychiatry,2000,57(3):277-283.
7Winzelberg AJ,Eppstein D,Eldredge KL,et al. Effectiveness of an Internet-based program for reducing risk factors for eating disorders. J Consult Clin Psychol,2000,68(2):346-349.
8Rossler W,Salize HJ,Cucchiaro G,et al. Dose the place of treatment influence the quality of life of schizophrenics?Acta Psychiatr Scand,1999,100(2):142-148.
9Lewis L. The national depressive and manic-depressive association:an introduction. Biol Psychiatry,2000,47(8):692-694.
10Kilian R,Holzinger A,Angermeyer MC. "It may be somewhat more demanding sometimes,but also more interesting". Psychiatrists evaluate the impact of psychoeducation on outpatient treatment of schizophrenia. Psychiatr Prax,2001,28(5):209-213.
